47 research outputs found
Cure psichiatriche territoriali ed ospedaliere: quale rapporto? Studio longitudinale in una USSL piemontese
Use of 1H MRS in the quantitative in vivo determination of the fat content in human liver steatosi
To demonstrate that the lipid volume fraction in liver steatosis can be accurately estimated with in vivo hydrogen-1 magnetic resonance (MR) spectroscopy, the authors developed a calibration procedure based on in vitro MR spectroscopy of lipid extracts from steatotic liver specimens. The lipid volume fractions determined with the calibration procedure were compared with the results of histomorphometry and with calibrated computed tomographic (CT) data. The volume fraction of fat determined with MR spectroscopy was in good agreement with the CT results, whereas histomorphometry underestimated the amount of hepatic fat. The results indicate that determination of the fat volume fraction in steatotic liver can be achieved noninvasively with MR spectroscopy
Pancreas preservation with University of Wisconsin and Celsior solutions
BACKGROUND:
Although the use of Celsior has been recently described for heart, lung, liver, and kidney transplantation, no data are available on its use for clinical pancreas preservation.
METHODS:
We herein describe the results of 112 pancreas transplants preserved with either University of Wisconsin (UW; (n = 56) or Celsior (n = 56) solution at two Italian transplant centers. The groups were comparable with regard to all donor and recipient characteristics.
RESULTS:
Mean cold and warm ischemia times were 10.1 +/- 2.2 hours and 37.2 +/- 8.2 minutes for UW compared to 10.8 +/- 2.4 hours and 38.3 +/- 6.7 minutes for Celsior (P = NS). Delayed endocrine pancreas function was recorded in two UW-preserved grafts (3.6%). Actuarial 1-year patient survival was 94.6% for UW as compared with 100% for Celsior (P = NS). Equivalent graft survival figures were 91.0% for UW as compared with 96.4% for Celsior (P = NS).
CONCLUSIONS:
Within the range of cold ischemia times reported in this study, UW and Celsior solutions have similar safety profiles for pancreas transplantation
CONSERVAZIONE DEL PANCREAS A SCOPO DI TRAPIANTO CON SOLUZIONE DELL’ UNIVERSITA’ DEL WISCONSIN O CELSIOR
CONSERVAZIONE DEL PANCREAS A SCOPO DI TRAPIANTO CON SOLUZIONE DELL’ UNIVERSITA’ DEL WISCONSIN O CELSIOR
CONSERVAZIONE DEL PANCREAS A SCOPO DI TRAPIANTO CON SOLUZIONE DELL’UNIVERSITA’ DEL WISCONSIN O CELSIOR
Pancreas preservation with university of wisconsin and celsior solutions
Background
Although the use of Celsior has been recently described for heart, lung, liver, and kidney transplantation, no data are available on its use for clinical pancreas preservation.
Methods
We herein describe the results of 112 pancreas transplants preserved with either University of Wisconsin (UW; (n = 56) or Celsior (n = 56) solution at two Italian transplant centers. The groups were comparable with regard to all donor and recipient characteristics.
Results
Mean cold and warm ischemia times were 10.1 ± 2.2 hours and 37.2 ± 8.2 minutes for UW compared to 10.8 ± 2.4 hours and 38.3 ± 6.7 minutes for Celsior (P = NS). Delayed endocrine pancreas function was recorded in two UW-preserved grafts (3.6%). Actuarial 1-year patient survival was 94.6% for UW as compared with 100% for Celsior (P = NS). Equivalent graft survival figures were 91.0% for UW as compared with 96.4% for Celsior (P = NS).
Conclusions
Within the range of cold ischemia times reported in this study, UW and Celsior solutions have similar safety profiles for pancreas transplantation